BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.543
+0.063 (1.81%)
Feb 5, 2025, 1:48 PM EST - Market open
BioLineRx Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 5, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 13 | 115 | 28 | 99 | 60 | 27 | |
| Market Cap Growth | -55.17% | 304.79% | -71.33% | 65.98% | 124.34% | -46.88% | |
| Enterprise Value | 14 | 102 | -19 | 40 | 47 | 7 | |
| Last Close Price | 3.48 | 62.80 | 23.60 | 81.60 | 100.80 | 90.00 | |
| PS Ratio | 2.39 | 24.01 | - | - | - | - | |
| PB Ratio | 6.19 | 8.72 | 0.56 | 1.46 | 2.72 | 0.80 | |
| P/TBV Ratio | - | - | 0.98 | 2.14 | 189.39 | 2.32 | |
| EV/Sales Ratio | 0.62 | 21.22 | - | - | - | - | |
| Debt / Equity Ratio | 3.48 | 0.88 | 0.24 | 0.07 | 0.35 | 0.31 | |
| Asset Turnover | 0.42 | 0.07 | - | - | - | - | |
| Quick Ratio | 1.33 | 1.43 | 4.85 | 5.89 | 2.14 | 2.35 | |
| Current Ratio | 1.52 | 1.53 | 4.87 | 5.91 | 2.15 | 2.36 | |
| Return on Equity (ROE) | -184.09% | -189.23% | -41.96% | -60.04% | -108.36% | -68.13% | |
| Return on Assets (ROA) | -32.96% | -38.30% | -23.10% | -24.07% | -28.42% | -32.00% | |
| Return on Capital (ROIC) | -53.91% | -61.08% | -26.82% | -30.23% | -38.97% | -37.43% | |
| Earnings Yield | -150.61% | -52.59% | -87.63% | -27.24% | -50.16% | -95.39% | |
| FCF Yield | -229.46% | -19.72% | -92.62% | -23.83% | -38.78% | -85.22% | |
| Buyback Yield / Dilution | -23.34% | -24.47% | -16.75% | -162.19% | -72.70% | -34.82% | |
| Total Shareholder Return | -23.34% | -24.47% | -16.75% | -162.19% | -72.70% | -34.82% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.